Your prediction
Fresenius SE & Co. KGaA ADR Stock
A very strong showing by Fresenius SE & Co. KGaA ADR today, with an increase of €0.40 (3.570%) compared to yesterday's price.
Pros and Cons of Fresenius SE & Co. KGaA ADR in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Fresenius SE & Co. KGaA ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Fresenius SE & Co. KGaA ADR | 3.570% | 2.655% | 16.000% | 1.754% | -1.695% | 56.757% | 0.870% |
| Fresenius SE & Co. KGaA | -0.130% | 0.107% | 13.739% | 3.483% | -4.008% | 55.585% | 1.382% |
| Fresenius Medical Care AG & Co KGaA ST | 0.220% | -2.678% | -2.885% | -3.614% | 0.761% | -8.693% | -40.253% |
| Universal Health Services B | -1.340% | -2.000% | 15.748% | -4.545% | -23.438% | 20.492% | 16.114% |
News
Fresenius Medical Care AG & Co. KGaA Q2 Earnings Call Highlights
Key Points
- Interested in Fresenius Medical Care AG & Co. KGaA? Here are five stocks we like better.
- Fresenius Medical Care reported solid Q2 results, with organic revenue up 5% and operating
Quest Diagnostics Q2 Earnings Call Highlights
Key Points
- Interested in Quest Diagnostics Incorporated? Here are five stocks we like better.
- Quest Diagnostics posted strong Q2 results, with revenue up 10.2% to $3.04 billion and adjusted